Our Research – Healthy Ageing

• Choice of empirical antibiotic therapy and adverse outcomes in older adults with suspected urinary tract infection: cohort study. 

• What do patients and family-caregivers value from hospice care? A systematic mixed studies review.

• Media content analysis of the introduction of a “soft opt-out” system of organ donation in Wales 2015-17.

• Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis.

• The need for comparative data in spondyloarthritis.

• Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis

• Emergency Risk Communication: Lessons Learned from a Rapid Review of Recent Gray Literature on Ebola, Zika, and Yellow Fever

• Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis

• Health Impact and Economic value of meeting housing quality standards; a retrospective longitudinal data linkage study

• Identifying patients with asthma-chronic obstructive pulmonary disease overlap syndrome using latent class analysis of electronic health record data: a study protocol

• Emergency hospital admissions associated with a non-randomised housing intervention meeting national housing quality standards: a longitudinal data linkage study

• Association between changes in lifestyle and all-cause mortality: the Health and Lifestyle Survey

• Changes in Health Behaviours and Longevity

• Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease – a population-wide electronic cohort study

• EULAR recommendations for management of fibromyalgia

• Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.

• Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.

• Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

• The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial.

• Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.